These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32781573)

  • 1. Menopausal Hormone Therapy and Risk of Endometrial Cancer: A Systematic Review.
    Tempfer CB; Hilal Z; Kern P; Juhasz-Boess I; Rezniczek GA
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A
    Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and the risk of endometrial cancer: A systematic review.
    Sjögren LL; Mørch LS; Løkkegaard E
    Maturitas; 2016 Sep; 91():25-35. PubMed ID: 27451318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of micronized progesterone on breast cancer risk: a systematic review.
    Stute P; Wildt L; Neulen J
    Climacteric; 2018 Apr; 21(2):111-122. PubMed ID: 29384406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of micronized progesterone on the endometrium: a systematic review.
    Stute P; Neulen J; Wildt L
    Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients.
    Orgéas CC; Hall P; Wedrén S; Dickman PW; Czene K
    Eur J Cancer; 2009 Nov; 45(17):3064-73. PubMed ID: 19493676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Menopausal Hormone Therapy with Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis of Cohort Studies.
    Jang YC; Leung CY; Huang HL
    Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):114-122. PubMed ID: 36306390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
    Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
    Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopause hormone treatment after cancer.
    Gompel A
    Climacteric; 2023 Jun; 26(3):240-247. PubMed ID: 37011657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
    Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
    Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
    Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health Study.
    Felix AS; Arem H; Trabert B; Gierach GL; Park Y; Pfeiffer RM; Brinton LA
    Cancer Causes Control; 2015 Aug; 26(8):1055-63. PubMed ID: 25962764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
    Simin J; Tamimi RM; Callens S; Engstrand L; Brusselaers N
    Int J Cancer; 2020 Jul; 147(1):33-44. PubMed ID: 31584190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone or progestin as menopausal ovarian hormone therapy: recent physiology-based clinical evidence.
    Prior JC
    Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):495-501. PubMed ID: 26512775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.